Evidence map›Paper›PMID 32380692›Full record

ArticleSensors (Basel, Switzerland)2020

Entropy of Real-World Gait in Parkinson's Disease Determined from Wearable Sensors as a Digital Marker of Altered Ambulatory Behavior.

Lucy Coates, Jian Shi, Lynn Rochester, Silvia Del Din, Annette Pantall

Open access · goldAbstract read
In one paragraph

Article in Sensors (Basel, Switzerland), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed, 3 pooled it
2.2field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 3 syntheses or guidelines pooled it, 53 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Article
  5. Article
  6. Review
  7. Article
  8. Observational
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Longitudinal Monitoring of Progressive Supranuclear Palsy using Body-Worn Movement Sensors.Movement disorders : official journal of the Movement Disorder Society · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Lucy CoatesSchool of Mathematics, Statistics and Physics, Newcastle University, Newcastle upon Tyne NE1 7RU, UK.
Jian ShiSchool of Mathematics, Statistics and Physics, Newcastle University, Newcastle upon Tyne NE1 7RU, UK.
Lynn RochesterTranslational and Clinical Research Unit, Clinical Ageing Research Unit, Newcastle University, Newcastle upon Tyne NE4 5PL, UK.
Silvia Del DinTranslational and Clinical Research Unit, Clinical Ageing Research Unit, Newcastle University, Newcastle upon Tyne NE4 5PL, UK.ORCID 0000-0003-1154-4751
Annette PantallTranslational and Clinical Research Unit, Clinical Ageing Research Unit, Newcastle University, Newcastle upon Tyne NE4 5PL, UK.ORCID 0000-0001-8504-2047
Newcastle University · GBNewcastle upon Tyne Hospitals NHS Foundation Trust · GB

Funding

NIHR Newcastle Biomedical Research Centre Institute supportNIHR/Wellcome Trust Clinical Research Facility (CRF) infrastructure at Newcastle upon Tyne Institute supportParkinson's UK G-1301Parkinson's UK J-0802Parkinson's UK J-0802, G-1301
6 · The paper itself

Abstract

Parkinson's disease (PD) is a common age-related neurodegenerative disease. Gait impairment is frequent in the later stages of PD contributing to reduced mobility and quality of life. Digital biomarkers such as gait velocity and step length are predictors of motor and cognitive decline in PD. Additional gait parameters may describe different aspects of gait and motor control in PD. Sample entropy (SampEnt), a measure of signal predictability, is a nonlinear approach that quantifies regularity of a signal. This study investigated SampEnt as a potential biomarker for PD and disease duration. Real-world gait data over a seven-day period were collected using an accelerometer (Axivity AX3, York, UK) placed on the low back and gait metrics extracted. SampEnt was determined for the stride time, with vector length and threshold parameters optimized. People with PD had higher stride time SampEnt compared to older adults, indicating reduced gait regularity. The range of SampEnt increased over 36 months for the PD group, although the mean value did not change. SampEnt was associated with dopaminergic medication dose but not with clinical motor scores. In conclusion, this pilot study indicates that SampEnt from real-world data may be a useful parameter reflecting clinical status although further research is needed involving larger populations.

Indexed as

Neurodegenerative DiseasesParkinson DiseaseWearable Electronic DevicesAgedBiomarkersEntropyGaitHumansPilot ProjectsQuality of LifeBiomarkersgaitParkinson’s diseasereal-worldsample entropyvariabilitywearable technology

Identifiers

PMID32380692
PMCPMC7249239
OpenAlexW3022296846

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.